TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3415853

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy with cisplatin and etoposide
Number of subjects: 95

Group type: COMPARATOR
Intervention: Radiotherapy (2.8 Gy x 15)
Number of subjects: 95
Study: 31958656

Group type: EXPERIMENTAL
Intervention: Clover honey
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sucrose
Number of subjects: 37
Study: 30409550

Group type: EXPERIMENTAL
Intervention: Culturally tailored text messages
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: BrainWorks Live
Number of subjects: 193

Group type: COMPARATOR
Intervention: General text messages
Number of subjects: 193
Study: 28855419

Group type: EXPERIMENTAL
Intervention: PRO40 (40 g casein)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: PRO20 (20 g casein)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: PRO20+LEU (20 g casein plus 1.5 g leucine)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 25543822

Group type: COMPARATOR
Intervention: Ceramide 2-containing hydrocolloid dressings with varying amounts of tackifying agent (TA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated applications of ceramide 2-containing hydrocolloid dressings with TA
Number of subjects: 0
Study: 22505055

Group type: EXPERIMENTAL
Intervention: Eccentric endurance exercise
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Concentric endurance exercise
Number of subjects: 45
Study: 22025591

Group type: COMPARATOR
Intervention: Intubate-Surfactant-Extubate (ISX)
Number of subjects: 648

Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Prophylactic surfactant (PS)
Number of subjects: 648
Study: 18682000

Group type: EXPERIMENTAL
Intervention: 3D‐PDS with contrast enhancement
Number of subjects: 42

Group type: COMPARATOR
Intervention: 3D‐PDS without contrast enhancement
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 3D‐PDS
Number of subjects: 42
Study: 16284236

Group type: EXPERIMENTAL
Intervention: Lower Body Suction (LBS)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cold Pressor Test (CPT)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Mental Arithmetic Task (MAT)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Activation of Muscle Chemoreflex (MCR)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control
Number of subjects: 11
Study: 12761262

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 690

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 690
Study: 10669692

Group type: EXPERIMENTAL
Intervention: RCP-directed treatments (Firm A, n = 239)
Number of subjects: 694

Group type: COMPARATOR
Intervention: Physician-directed treatments (Firms B and C)
Number of subjects: 694
Study: 9411036

Group type: EXPERIMENTAL
Intervention: 26-gauge Atraucan
Number of subjects: 100

Group type: COMPARATOR
Intervention: 27-gauge Whitacre
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 8161671

Group type: EXPERIMENTAL
Intervention: Nizatidine 300 mg
Number of subjects: 245

Group type: COMPARATOR
Intervention: Ranitidine 300 mg
Number of subjects: 245
Study: 3083519

Group type: EXPERIMENTAL
Intervention: TRH 200 micrograms
Number of subjects: 0

Group type: COMPARATOR
Intervention: TRH 500 micrograms
Number of subjects: 0
Study: 31373524

Group type: EXPERIMENTAL
Intervention: Child Anxiety Learning Modules (CALM)
Number of subjects: 54

Group type: COMPARATOR
Intervention: CALM-Relaxation only (CALM-R)
Number of subjects: 54
Study: 30821830

Group type: EXPERIMENTAL
Intervention: Internal‐external facilitation for 1 year
Number of subjects: 5596
Study: 28851443

Group type: EXPERIMENTAL
Intervention: Two approaches to speech and language therapy (SLT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No SLT intervention (control)
Number of subjects: 0
Study: 26534754

Group type: EXPERIMENTAL
Intervention: Pediatric MENDs (mechanical external nasal dilators)
Number of subjects: 56
Study: 23895315

Group type: EXPERIMENTAL
Intervention: Responsive Classroom® (RC) approach
Number of subjects: 1561

Group type: COMPARATOR
Intervention: Fewer RC practices
Number of subjects: 1561
Study: 21346062

Group type: EXPERIMENTAL
Intervention: Dietary methionine restriction (MR) at 2 mg methionine/kg body weight per day
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group with 33 mg methionine/kg body weight per day
Number of subjects: 26
Study: 18434580

Group type: EXPERIMENTAL
Intervention: Dental amalgam fillings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Composite fillings
Number of subjects: 0
Study: 17151158

Group type: COMPARATOR
Intervention: Perphenazine
Number of subjects: 1493

Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotics (olanzapine, quetiapine, risperidone, ziprasidone)
Number of subjects: 1493
Study: 14555296

Group type: EXPERIMENTAL
Intervention: Didanosin (DDI) containing regimen
Number of subjects: 116

Group type: COMPARATOR
Intervention: Non-DDI group
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Didanosin (DDI) plus D4T and EFV
Number of subjects: 116
Study: 11128915

Group type: EXPERIMENTAL
Intervention: Bioabsorbable membrane with demineralized freeze-dried bone allograft (DFDBA)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Bioabsorbable membrane without demineralized freeze-dried bone allograft (DFDBA)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both treatments (with and without DFDBA)
Number of subjects: 14
Study: 9069293

Group type: COMPARATOR
Intervention: External beam radiation therapy (EBRT) alone (Group 1)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 3 months of neoadjuvant combination therapy (LHRH‐agonist + Flutamide) prior to EBRT (Group 2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination therapy 3 months before, during, and 6 months after EBRT (Group 3)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 8450178

Group type: EXPERIMENTAL
Intervention: High dose L-carnitine (6 gr per day for two weeks)
Number of subjects: 0
Study: 3790388

Group type: EXPERIMENTAL
Intervention: 1% halothane
Number of subjects: 30

Group type: COMPARATOR
Intervention: 70% nitrous oxide in oxygen
Number of subjects: 30
Study: 31065837

Group type: EXPERIMENTAL
Intervention: Nurse-led informational-emotional support program (5 face-to-face sessions, educational booklet, 5 phone follow-ups over 10 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine cares (Control group)
Number of subjects: 80
Study: 30149474

Group type: EXPERIMENTAL
Intervention: Gastric lavage (GL) with 10 ml/kg of normal saline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no gastric lavage)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gastric lavage (GL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gastric lavage (GL) and Control group
Number of subjects: 0
Study: 28598927

Group type: EXPERIMENTAL
Intervention: ANI-guided fentanyl administration
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (standard clinical practice)
Number of subjects: 50
Study: 26625940

Group type: EXPERIMENTAL
Intervention: Frailty index (FI) increase by 0.01
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Frailty defined as FI >= 0.25
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Frailty index (FI)
Number of subjects: 248
Study: 23930718

Group type: EXPERIMENTAL
Intervention: Anterior cervical discectomy decompression with autologous iliac crest bone grafting and internal plate fixation (DDF group: 24 patients)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Anterior cervical corpectomy, posterior longitudinal ligament resection, autologous iliac crest bone grafting, and internal plate fixation (CDF group: 24 patients)
Number of subjects: 48
Study: 21077016

Group type: EXPERIMENTAL
Intervention: Red colour comparison test
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Green colour comparison test
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Blue colour comparison test
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Any of the 3 colours
Number of subjects: 101

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 101
Study: 18804999

Group type: EXPERIMENTAL
Intervention: MDT recommended patients
Number of subjects: 350

Group type: COMPARATOR
Intervention: No MDT recommendation
Number of subjects: 350
Study: 16611335

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 650

Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 650
Study: 14563573

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 1224

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 1224

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 1224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1224
Study: 11868167

Group type: EXPERIMENTAL
Intervention: Hydrofibre dressing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional dressing (ribbon gauze soaked in proflavine)
Number of subjects: 0
Study: 8777885

Group type: EXPERIMENTAL
Intervention: Intermittent impulse compression using the AV impulse device (Novamedix Inc.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cryotherapy (standard therapy using cool packs)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intermittent impulse compression
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 40
Study: 1678028

Group type: EXPERIMENTAL
Intervention: breastmilk only
Number of subjects: 45

Group type: COMPARATOR
Intervention: breastmilk plus supplemental fluid
Number of subjects: 45
Study: 7116616

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate as a powder
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate as a pressurized aerosol
Number of subjects: 42

Group type: COMPARATOR
Intervention: Both treatments (aerosol and powder)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Blind microscopy of wiped nasal-smears
Number of subjects: 42

Group type: COMPARATOR
Intervention: Counting of sneezes after medication
Number of subjects: 42
Study: 30105456

Group type: EXPERIMENTAL
Intervention: Shock wave lithotripsy (SWL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Visual cystolitholapaxy (endoscopy group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups (SWL and endoscopy)
Number of subjects: 100
Study: 29073916

Group type: EXPERIMENTAL
Intervention: Calcium supplementation before pregnancy
Number of subjects: 1354
Study: 25728722

Group type: EXPERIMENTAL
Intervention: Continuous chest compressions without interruption for ventilation
Number of subjects: 23600

Group type: COMPARATOR
Intervention: Interrupted chest compressions with positive pressure ventilations at a ratio of 30:2
Number of subjects: 23600
Study: 24168901

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 23

Group type: COMPARATOR
Intervention: Conventional rotative instruments
Number of subjects: 23
Study: 21480950

Group type: EXPERIMENTAL
Intervention: telcagepant 500 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22
Study: 19838896

Group type: EXPERIMENTAL
Intervention: Prostate cancer educational program
Number of subjects: 345
Study: 17272359

Group type: EXPERIMENTAL
Intervention: Rhythm control in hypertensives
Number of subjects: 522

Group type: COMPARATOR
Intervention: Rate control
Number of subjects: 522
Study: 15135275

Group type: EXPERIMENTAL
Intervention: Fluoroscopic guidance
Number of subjects: 42

Group type: COMPARATOR
Intervention: Surgical navigation
Number of subjects: 42
Study: 11696209

Group type: EXPERIMENTAL
Intervention: Stretching group (STR) - 40 min, 3 days per week session of thigh and calf muscle stretching exercises for 10 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-stretching group (CON)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both STR and CON
Number of subjects: 32
Study: 10205986

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8724298

Group type: EXPERIMENTAL
Intervention: DHEAS in female patients with SLE
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: DHEAS in male patients with SLE
Number of subjects: 35

Group type: COMPARATOR
Intervention: DHEAS levels in SLE patients
Number of subjects: 35
Study: 2180472

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 51

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 51
Study: 7437212

Group type: EXPERIMENTAL
Intervention: Deliberate hypotension (mean arterial pressure decreased to 55 mm Hg by sodium nitroprusside)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Normovolaemic haemodilution (23 +/- 2 ml/kg of blood withdrawn, replaced by twice volume with 4% albumin and Ringer lactate solution)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (blood replacement equal to blood loss)
Number of subjects: 30
Study: 31876300

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) trained on maximizing prostate overlap and minimizing registration errors
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) variant trained to optimize prostate overlap
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) variant trained to optimize registration
Number of subjects: 5

Group type: COMPARATOR
Intervention: Elastix (open-source deformable registration software)
Number of subjects: 5
Study: 30851351

Group type: EXPERIMENTAL
Intervention: Hyperbaric Oxygen (HBO) administered in 30 daily dives at 100% oxygen to a pressure of 2.4 atmospheres absolute for 80 to 90 minutes.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no HBO treatment).
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hyperbaric Oxygen (HBO) group.
Number of subjects: 100
Study: 28876301

Group type: EXPERIMENTAL
Intervention: Disclosure intervention group
Number of subjects: 337

Group type: COMPARATOR
Intervention: Attention control case management group
Number of subjects: 337
Study: 25467852

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 24552383

Group type: EXPERIMENTAL
Intervention: Hypoxic ambulatory confinement (HAMB; FIO2 = 0.147; PIO2 = 93.8 mm Hg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hypoxic bed rest (HBR; FIO2 = 0.147; PIO2 = 93.8 mm Hg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Normoxic bed rest (NBR; FIO2 = 0.209; PIO2 = 133.5 mm Hg)
Number of subjects: 11
Study: 23198915

Group type: EXPERIMENTAL
Intervention: PCOS patients
Number of subjects: 217

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 217
Study: 21156909

Group type: EXPERIMENTAL
Intervention: Sildenafil (100 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 16949877

Group type: EXPERIMENTAL
Intervention: Prolonged wrist flexion (15 min) in symptomatic patients
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Prolonged wrist flexion (15 min) in symptomatic patients with normal conduction latency (n = 13)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Prolonged wrist flexion (15 min) in symptomatic patients with abnormal conduction latency (n = 21)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (n = 36)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Correlation of conduction latency with tactile threshold
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Correlation of conduction latency with 15-min threshold in subpopulation with abnormal conduction latency
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Correlation at 2.5 min after flexion
Number of subjects: 49
Study: 16290894

Group type: EXPERIMENTAL
Intervention: Swedish massage on back, neck, and chest (BNC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Swedish massage on leg, arm, and face (LAF)
Number of subjects: 0
Study: 12039820

Group type: EXPERIMENTAL
Intervention: Intraoperative cell salvage
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control group (no mechanical blood conservation)
Number of subjects: 263
Study: 9234029

Group type: EXPERIMENTAL
Intervention: Clinical eating disorder (n = 14)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Subclinical eating disorder (n = 13)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Women who intentionally omitted or reduced insulin
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Bulimic behaviours
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (n = 63)
Number of subjects: 90
Study: 8497636

Group type: EXPERIMENTAL
Intervention: Film interpretation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Teleradiology system interpretation
Number of subjects: 120
Study: 3688570

Group type: EXPERIMENTAL
Intervention: IgG anti-cow's milk antibody
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: IgE levels
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Food sensitization (food-specific IgE)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Signs and symptoms of atopic allergy diseases
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cow's milk-specific IgG antibody
Number of subjects: 200
Study: 29172715

Group type: EXPERIMENTAL
Intervention: Telemonitoring: weekly assessment of transmitted HBP by physicians and treatment adjustment upon office visits
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Telemedicine: online communication instead of office visits to adjust medication using telemonitored HBP
Number of subjects: 444

Group type: COMPARATOR
Intervention: Control: usual care with office visits and HBP self‐report
Number of subjects: 444
Study: 26488126

Group type: EXPERIMENTAL
Intervention: PCC 37.5 iu/kg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: PCC 25 iu/kg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 25212580

Group type: EXPERIMENTAL
Intervention: Virtual World (VW)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Face-to-Face (F2F)
Number of subjects: 32
Study: 22551811

Group type: EXPERIMENTAL
Intervention: 30 μg hemagglutinin (HA) alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.5 μg HA and Matrix M adjuvant (50 μg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 7.5 μg HA and Matrix M adjuvant (50 μg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 30 μg HA and Matrix M adjuvant (50 μg)
Number of subjects: 60
Study: 20973989

Group type: EXPERIMENTAL
Intervention: Elective birth at 37 weeks gestation
Number of subjects: 460

Group type: COMPARATOR
Intervention: Standard care (birth planned for 38 weeks gestation or later)
Number of subjects: 460
Study: 18403736

Group type: EXPERIMENTAL
Intervention: DP‐b99 (1 mg/kg per day for 4 days)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: DP‐b99
Number of subjects: 150
Study: 16034832

Group type: EXPERIMENTAL
Intervention: Dissecting sealer
Number of subjects: 94

Group type: COMPARATOR
Intervention: Clamp crushing method
Number of subjects: 94
Study: 11808836

Group type: EXPERIMENTAL
Intervention: Sarpogrelate (200 mg, oral administration)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 15
Study: 10064252

Group type: EXPERIMENTAL
Intervention: Fluconazole (400 mg daily)
Number of subjects: 274
Study: 7723301

Group type: EXPERIMENTAL
Intervention: Cocaine hydrochloride 50 mg intranasally
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cocaine hydrochloride 126 mg intranasally
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sweat patch technology
Number of subjects: 36

Group type: COMPARATOR
Intervention: Nondrug users wearing patches
Number of subjects: 36
Study: 1867149

Group type: EXPERIMENTAL
Intervention: Community intervention for smoking cessation over 4 years
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (matched pairs of communities)
Number of subjects: 22
Study: 6355207

Group type: EXPERIMENTAL
Intervention: 150 mg/day of amitriptyline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 60 mg/day of phenelzine
Number of subjects: 0
Study: 31249253

Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg administered sublingually 50 minutes before surgery
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo administered sublingually 50 minutes before surgery
Number of subjects: 88
Study: 29139325

Group type: EXPERIMENTAL
Intervention: Resilience training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 26718698

Group type: EXPERIMENTAL
Intervention: Pregabalin 300mg
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135

Group type: COMPARATOR
Intervention: Pregabalin 150mg
Number of subjects: 135
Study: 24129964

Group type: EXPERIMENTAL
Intervention: Outcome pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monitoring pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher stress appraisals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher stress reactivity (heart rate)
Number of subjects: 0
Study: 22846236

Group type: EXPERIMENTAL
Intervention: Injunctive norms, age, and past DAD behavior
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Participants' perceptions of peers' approval of DAD
Number of subjects: 655
Study: 19110224

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 100 mg/d
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 150 mg/d
Number of subjects: 458

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 458
Study: 17718786

Group type: EXPERIMENTAL
Intervention: Metformin (500 mg bid)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 16398436

Group type: EXPERIMENTAL
Intervention: Qianggu capsules (QGC), 1 capsule (180 mg) each time, three times a day for three months
Number of subjects: 65

Group type: COMPARATOR
Intervention: D-Cal Biocal, 2 tablets (1500 mg) each time, once daily for three months
Number of subjects: 65
Study: 12593456

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 9842630

Group type: EXPERIMENTAL
Intervention: Computer-based system (FitLinxx Interactive Fitness Network)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Standard exercise tracking and feedback
Number of subjects: 164
Study: 8590616

Group type: EXPERIMENTAL
Intervention: ritanserin (10 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 2672380

Group type: EXPERIMENTAL
Intervention: nimesulide (200 mg/day p.o.)
Number of subjects: 80

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 80